Sepsis-Associated Encephalopathy (Review)

International studies demonstrate an annual increase in the frequency and impact of sepsis in intensive care units (ICU). Cerebral dysfunction, or so-called sepsis-associated encephalopathy (SAE), is one of the earliest signs of sepsis, as well as its common complication. Up to 70% of patients with sepsis have symptoms of encephalopathy [1, 2]. A direct link between the SAE and an increased mortality rate is a major concern; more than a half of sepsis survivors experience continuous memory and concentration impairment [3—5]. Diagnosis of the cerebral dysfunction in sepsis is often difficult because of lack of specific biomarkers and frequent prescription of sedatives to critically ill patients. Clinical manifestations of SAE are diverse, may vary from simple malaise and lack of concentration to deep coma. The literature discusses probable mechanisms of formation and development of septic encephalopathy, such as oxidative stress, inflammation, mitochondrial and endothelial dysfunction, increased permeability of the blood-brain barrier, impairment of macro- and microcirculation, changes in neirotransmission, activation of microglia. The lack of clear data and consensus about the etiology and mechanisms of SAE at present does not permit predicting its development and prescribing a specific therapy. The review discusses current understanding of the causes of septic encephalopathy, methods of diagnosis, the main clinical manifestations, key mediators, and pathophysiological mechanisms. A hypothesis is proposed that poses a contribution of aromatic microbial metabolites (AMM) of phenol and indole nature (products of bacterial biodegradation of tyrosine and tryptophan) to the development of brain dysfunction. The fields of exploratory studies, which might open perspectives in the diagnosis, as well as new approaches in the treatment of SAE are outlined.

sepsis, brain, delirium, encephalopathy, biomarkers

1. Ziaja M. Septic encephalopathy. Curr. Neurol. Neurosci. Rep. 2013; 13 (10): 383. DOI: 10.1007/s11910-013-0383-y. PMID: 23954971

2. Chaudhry N., Duggal A.K. Sepsis associated encephalopathy. Adv. Med. 2014; 2014: 762320. DOI: 10.1155/2014/762320. PMID: 26556425

3. Pinheiro da Silva F., Machado M.C., Velasco I.T. Neuropeptides in sepsis: from brain pathology to systemic inflammation. Peptides. 2013; 44: 135-138. DOI: 10.1016/j.peptides.2013.03.029. PMID: 23583479

4. Annane D., Sharshar T. Cognitive decline after sepsis. Lancet Respir. Med. 2015; 3 (1): 61-69. DOI: 10.1016/S2213-2600(14)70246-2. PMID: 25434614

5. Kaur J., Singhi P., Singhi S., Malhi P., Saini A.G. Neurodevelopmental and behavioral outcomes in children with sepsis-associated encephalopathy admitted to pediatric intensive care unit: a prospective case control study. J. Child Neurol. 2015; 31 (6): 683-690. DOI: 10.1177/0883073815610431. PMID: 26500243

6. Vincent J.L., Abraham E. The last 100 years of sepsis. Am. J. Respir. Crit. Care Med. 2006; 173 (3): 256-263. DOI: 10.1164/rccm.200510-1604OE. PMID: 16239619

7. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., Sevransky J.E., Sprung C.L., Douglas I.S., Jaeschke R., Osborn T.M., Nunnally M.E., Townsend S.R., Reinhart K., Kleinpell R.M., Angus D.C., Deutschman C.S., Machado F.R., Rubenfeld G.D., Webb S.A., Beale R.J., Vincent J.L., Moreno R.; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Crit. Care Med. 2013; 41 (2): 580-637. DOI: 10.1097/CCM.0b013e31827e83af. PMID: 23352941

8. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001; 29 (7): 1303-1310. DOI: 10.1097/00003246-200107000-00002. PMID: 11445675

9. Jacob A., Brorson J.R., Alexander J.J. Septic encephalopathy: Inflammation in man and mouse. Neurochem. Int. 2011; 58 (4): 472–476. DOI: 10.1016/j.neuint.2011.01.004. PMID: 21219956

10. Piva S., McCreadie V.A., Latronico N. Neuroinflammation in sepsis: sepsis associated delirium. Cardiovasc. Hematol. Disord. Drug Targets. 2015; 15 (1): 10-18. DOI: 10.2174/1871529X15666150108112452. PMID: 25567339

11. Wilson J. X., Young G.B. Progress in clinical neurosciences: sepsis-associated encephalopathy: evolving concepts. Can. J. Neurol. Sci. 2003; 30 (2): 98-105. DOI: 10.1017/S031716710005335X. PMID: 12774948

12. Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M., Bellomo R., Bernard G.R., Chiche J.D., Coopersmith C.M., Hotchkiss R.S., Levy M.M., Marshall J.C., Martin G.S., Opal S., Rubenfeld G.D., van der Poll T., Vincent J.L., Angus D.C. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315 (8): 801-810. DOI: 10.1001/jama.2016.0287. PMID: 26903338

13. Zampieri F.G., Park M., Machado F.S., Azevedo L.C. Sepsis-associated encephalopathy: not just delirium. Clinics (Sao Paulo). 2011; 66 (10): 1825-1831. DOI: 10.1590/S1807-59322011001000024. PMID: 22012058

14. Ebersoldt M., Sharshar T., Annane D. Sepsis-associated delirium. Intensive Care Med. 2007; 33 (6): 941–950. DOI: 10.1007/s00134-007-0622-2. PMID: 17410344

15. Gofton T.E., Young G.B. Sepsis-associated encephalopathy. Nat. Rev. Neurol. 2012; 8 (10): 557-566. DOI: 10.1038/nrneurol.2012.183. PMID: 22986430

16. Maltseva L.A., Bazilenko D.V. The role of sepsis-associated encephalopathy in the formation of multiorgan insufficiency syndrome in patients with severe sepsis and septic shock. Vestnik Intensivnoi Terapii. 2015; 3: 11-15. [In Russ.]

17. Young G.B. Encephalopathy of infection and systemic inflammation. J. Clin. Neurophysiol. 2013; 30 (5): 454-461. DOI: 10.1097/WNP.0b013e 3182a73d83. PMID: 24084178

18. Hosokawa K., Gaspard N., Su F., Oddo M., Vincent J.-L., Taccone F.S. Clinical neurophysiological assessment of sepsis associated brain dysfunction: a systematic review. Crit. Care. 2014; 18 (6): 674. DOI: 10.1186/s13054-014-0674-y. PMID: 25482125

19. Piazza O., Cotena S., De Robertis E., Caranci F., Tufano R. Sepsis associated encephalopathy studied by MRI and cerebral spinal fluid S100B measurement. Neurochem. Res. 2009; 34 (7): 1289-1292. DOI: 10.1007/s11064-008-9907-2. PMID: 19132530

20. Sharshar T., Carlier R., Bernard F., Guidoux C., Brouland J.P., Nardi O., de la Grandmaison G.L., Aboab J., Gray F., Menon D., Annane D. Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med. 2007; 33 (5): 798–806. DOI: 10.1007/s00134-007-0598-y. PMID: 17377766

21. Oddo M., Taccone F.S. How to monitor the brain in septic patients? Minerva Anestesiologica. 2015; 81 (7): 776-788. PMID: 25812488

22. Stubbs D.J., Yamamoto A.K., Menon D.K. Imaging in sepsis-associated encephalopathy-insights and opportunities. Nat. Rev. Neurol. 2013; 9 (10): 551-561. DOI: 10.1038/nrneurol.2013.177. PMID: 23999468

23. Pfister D., Siegemund M., Dell-Kuster S., Smielewski P., Rüegg S., Strebel S.P., Marsch S.C., Pargger H., Steiner L.A. Cerebral perfusion in sepsis-associated delirium. Crit. Care. 2008; 12 (3): R63. DOI: 10.1186/cc6891. PMID: 18457586

24. Szatmári S., Végh T., Csomós A., Hallay J., Takács I., Molnár C., Fülesdi B. Impaired cerebrovascular reactivity in sepsis-associated encephalopathy studied by acetazolamide test. Crit. Care. 2010; 14 (2): R50. DOI: 10.1186/cc8939. PMID: 20356365

25. Busygin S.N., Klink Yu.P., Bubnova I.D. Hemodynamics regulation and serum level of protein S100 in septic encephalopathy. Uralsky Meditsinsky Zhurnal. 2013; 3 (108): 53-57. [In Russ.]

26. Zenaide P. V., Gusmao-Flores D. Biomarkers in septic encephalopathy: a systematic review of clinical studies. Rev. Bras. Ter. Intensiva. 2013; 25 (1): 56-62. PMID: 23887761

27. Yao B., Zhang L.N., Ai Y.H., Liu Z.Y., Huang L. Serum S100в is a better biomarker than neuron-specific enolase for sepsis-associated encephalopathy and determining its prognosis: a prospective and observational study. Neurochem. Res. 2014; 39 (7): 1263-1269. DOI: 10.1007/s11064-014-1308-0. PMID: 24760429

28. Gashilova F.F., Zhukova N.G. Neuron-specific enolase in the blood serum as a diagnostic marker of parkinsonism. Byulleten Sibirskoi Meditsiny. 2005; 4 (3): 28-33. [In Russ.]

29. Nguyen D.N., Spapen H., Su F., Schiettecatte J., Shi L., Hachimi-Idrissi S., Huyghens L. Elevated serum levels of S-100 protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit. Care Med. 2006; 34 (7): 1967–1974. DOI: 10.1097/01.CCM.0000217218.51381.49. PMID: 16607230

30. Hsu A.A., Fenton K., Weinstein S., Carpenter J., Dalton H., Bell M.J. Neurological injury markers in children with septic shock. Pediatr. Crit. Care Med. 2008; 9 (3): 245–251. DOI: 10.1097/PCC.0b013e3181727b22. PMID: 18446104

31. Tomasi C.D., Vuolo F., Generoso J., Soares M., Barichello T., Quevedo J., Ritter C., Dal-Pizzol F. Вiomarkers of delirium in a low-risk community-acquired pneumonia-induced sepsis. Mol. Neurobiol. 2017; 54 (1): 722-726. DOI: 10.1007/s12035-016-9708-6. PMID: 26768428

32. Comim C.M., Cassol-Jr O.J., Constantino L.C., Petronilho F., Constantino L.S., Stertz L., Kapczinski F., Barichello T., Quevedo J., Dal-Pizzol F. Depressive-like parameters in sepsis survivor rats. Neurotox. Res. 2010; 17 (3): 279-286. DOI: 10.1007/s12640-009-9101-6. PMID: 19705213

33. Comim C.M., Silva N.C., Mina F., Dominguini D., Scaini G., Morais M.O., Rosa D.V., Magno L.A., Streck E.L., Romano-Silva M.A., Quevedo J., DalPizzol F. Evaluation of NCS-1, DARPP-32, and neurotrophins in hippocampus and prefrontal cortex in rats submitted to sepsis. Synapse. 2014; 68 (10): 474-479. DOI: 10.1002/syn.21760. PMID: 24978930

34. Vasconcelos A.R., Yshii L.M., Viel T.A., Buck H.S., Mattson M.P., Scavone C., Kawamoto E.M. Intermittent fasting attenuates lipopolysaccharideinduced neuroinflammation and memory impairment. J. Neuroinflammation. 2014; 11: 85. DOI: 10.1186/1742-2094-11-85. PMID: 24886399

35. Ritter C., Miranda A.S., Giombelli V.R., Tomasi C.D., Comim C.M., Teixeira A.L., Quevedo J., Dal-Pizzol F. Brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injury. Crit. Care. 2012; 16 (6): R234. DOI: 10.1186/cc11902. PMID: 23245494

36. Girard T.D., Jackson J.C., Pandharipande P.P., Pun B.T., Thompson J.L., Shintani A.K., Gordon S.M., Canonico A.E., Dittus R.S., Bernard G.R., Ely E.W. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit. Care Med. 2010; 38 (7): 1513–1520. DOI: 10.1097/CCM.0b013e3181e47be1. PMID: 20473145

37. Sweis R., Ortiz J., Biller J. Neurology of sepsis. Curr. Neurol. Neurosci. Rep. 2016; 16 (3): 21. DOI: 10.1007/s11910-016-0623-z. PMID: 26820754

38. Tanaka T., Sunden Y., Sakoda Y., Kida H., Ochiai K., Umemura T. Lipopolysaccharide treatment and inoculation of influenza A virus results in influenza virus-associated encephalopathy-like changes in neonatal mice. J. Neurovirol. 2010; 16 (2): 125–132. DOI: 10.3109/ 13550281003682521. PMID: 20345319

39. Flierl M.A., Stahel P.F., Rittirsch D., Huber-Lang M., Niederbichler A.D., Hoesel L.M., Touban B.M., Morgan S.J., Smith W.R., Ward P.A., Ipaktchi K. Inhibition of complement C5a prevents breakdown of the blood– brain barrier and pituitary dysfunction in experimental sepsis. Crit. Care. 2009; 13 (1): R12. DOI: 10.1186/cc7710. PMID: 19196477

40. Barichello T., Machado R.A., Constantino L., Valvassori S.S., Réus G.Z., Martins M.R., Petronilho F., Ritter C., Quevedo J., Dal-Pizzol F. Antioxidant treatment prevented late memory impairment in an animal model of sepsis. Crit. Care Med. 2007; 35 (9): 2186-2190. DOI: 10.1097/01.CCM.0000281452.60683.96. PMID: 17855835

41. Calsavara A.C., Rodrigues D.H., Miranda A.S., Costa P.A., Lima C.X., Vilela M.C., Rachid M.A., Teixeira A.L. Late anxiety-like behavior and neuroinflammation in mice subjected to sublethal polymicrobial sepsis. Neurotox. Res. 2013; 24 (2): 103-108. DOI: 10.1007/s12640-012-9364-1. PMID: 23224747

42. Gao R., Kan M.Q., Wang S.G., Yang R.H., Zhang S.G.. Disrupted tryptophan metabolism induced cognitive impairment in a mouse model of sepsis-associated encephalopathy. Inflammation. 2016; 39 (2): 550-560. DOI: 10.1007/s10753-015-0279-x. PMID: 26508338

43. Wu J., Zhang M., Hao S., Jia M., Ji M., Qiu L., Sun X., Yang J., Li K. Mitochondria-targeted peptide reverses mitochondrial dysfunction and cognitive deficits in sepsis-associated tncephalopathy. Mol. Neurobiol. 2015; 52 (1): 783-791. DOI: 10.1007/s12035-014-8918-z. PMID: 25288156

44. Venturi L., Miranda M., Selmi V., Vitali L., Tani A., Margheri M., De Gaudio A.R., Adembri C. Systemic sepsis exacerbates mild post-traumatic brain injury in the rat. J. Neurotrauma. 2009; 26 (9): 1547-1556. DOI: 10.1089/neu.2008-0723. PMID: 19257801

45. Semmler A., Frisch C., Debeir T., Ramanathan M., Okulla T., Klockgether T., Heneka M.T. Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model. Exp. Neurol. 2007; 204 (2): 733-740. DOI: 10.1016/j.expneurol.2007.01.003. PMID: 17306796

46. Janz D.R., Abel T.W., Jackson J.C., Gunther M., Heckers S., Ely E.W. Brain autopsy findings in intensive care unit patients previously suffering from delirium: a pilot study. J. Crit. Care. 2010; 25 (3): 538.e7-538.e12. DOI: 10.1016/j.jcrc.2010.05.004. PMID: 20580199

47. Semmler A., Hermann S., Mormann F., Weberpals M., Paxian S.A., Okulla T., Schäfers M., Kummer M.P., Klockgether T., Heneka M.T. Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J. Neuroinflammation. 2008; 5: 38. DOI: 10.1186/1742-2094-5-38. PMID: 18793399

48. Yokoo H., Chiba S., Tomita K., Takashina M., Sagara H., Yagisita S., Takano Y., Hattori Y. Neurodegenerative evidence in mice brains with cecal ligation and puncture-induced sepsis: preventive effect of the free radical scavenger edaravone. PLoS One. 2012; 7 (12): e51539. DOI: 10.1371/journal.pone.0051539. PMID: 23236515

49. Papadopoulos M.C., Lamb F.J., Moss R.F., Davies D.C., Tighe D., Bennett E.D. Faecal peritonitis causes oedema and neuronal injury in pig cerebral cortex. Clin. Sci. (Lond.). 1999; 96 (5): 461–466. DOI: 10.1042/CS19980327. PMID: 10209077

50. Sharshar T., Gray F., Poron F., Raphael J.C., Gajdos P., Annane D. Multifocal necrotizing leukoencephalopathy in septic shock. Crit. Care Med. 2002; 30 (10): 2371-2375. DOI: 10.1097/00003246-200210000-00031. PMID: 12394971

51. Messaris E., Memos N., Chatzigianni E., Konstadoulakis M.M., Menenakos E., Katsaragakis S., Voumvourakis C., Androulakis G. Time-dependent mitochondrial-mediated programmed neuronal cell death prolongs survival in sepsis. Crit. Care Med. 2004; 32 (8): 1764-1770. DOI: 10.1097/01.CCM.0000135744.30137.B4. PMID: 15286556

52. Liu L., Xie K., Chen H., Dong X., Li Y., Yu Y., Wang G., Yu Y. Inhalation of hydrogen gas attenuates brain injury in mice with cecal ligation and puncture via inhibiting neuroinflammation, oxidative stress and neuronal apoptosis. Brain Res. 2014; 1589: 78-92. DOI: 10.1016/j.brainres.2014.09.030. PMID: 25251596

53. Bozza F.A., D’Avila J.C., Ritter C., Sonneville R., Sharshar T., Dal-Pizzol F. Bioenergetics, mitochondrial dysfunction, and oxidative stress in the pathophysiology of septic encephalopathy. Shock. 2013; 39 (Suppl 1): 10-16. DOI: 10.1097/SHK.0b013e31828fade1. PMID: 23481496

54. Green R., Scott L.K., Minagar A., Conrad S. Sepsis associated encephalopathy (SAE): a review. Front. Biosci. 2004; 9: 1637–1641. DOI: 10.2741/1250. PMID: 14977574

55. Basler T., Meier-Hellmann A., Bredle D., Reinhart K. Amino acid imbalance early in septic encephalopathy. Intensive Care Med. 2002; 28 (3): 293–298. DOI: 10.1007/s00134-002-1217-6. PMID: 11904658

56. Azevedo L.C. Mitochondrial dysfunction during sepsis. Endocr. Metab. Immune Disord. Drug Targets. 2010; 10 (3): 214-223. PMID: 20509844

57. Белобородова Н.В., Теплова В.В., Федотчева Н.И. Роль микробных метаболитов в дисфункции митохондрий при сепсисе. Саарбрюккен: Lambert Academic Publishing; 2013: 96.

58. Nico B., Ribatti D. Morphofunctional aspects of the blood–brain barrier. Curr. Drug Metab. 2012; 13 (1): 50–60. PMID: 22292807

59. Taccone F.S., Castanares-Zapatero D., Peres-Bota D., Vincent J.L., Berre J., Melot C. Cerebral autoregulation is influenced by carbon dioxide levels in patients with septic shock. Neurocrit. Care. 2010; 12 (1): 35–42. DOI: 10.1007/s12028-009-9289-6. PMID: 19806473

60. Taccone F.S., Scolletta S., Franchi F., Donadello K., Oddo M. Brain perfusion in sepsis. Curr. Vasc. Pharmacol. 2013; 11 (2): 170-186. PMID: 23506496

61. Soejima Y., Fujii Y., Ishikawa T., Takeshita H., Maekawa T. Local cerebral glucose utilization in septic rats. Crit. Care Med. 1990; 18 (4): 423-427. DOI: 10.1097/00003246-199004000-00015. PMID: 2318053

62. Simonenkov A.P., Klyuzhev V.M. Syndrome of serotonin deficiency. Moscow: Binom; 2013: 96. [In Russ.]

63. Bilbo S.D., Barrientos R.M., Eads A.S., Northcutt A., Watkins L.R., Rudy J.W., Maier S.F. Early-life infection leads to altered BDNF and IL1beta mRNA expression in rat hippocampus following learning in adulthood. Brain Behav. Immun. 2008; 22 (4): 451-455. DOI: 10.1016/j.bbi.2007.10.003. PMID: 17997277

64. Ertug˘rul A., Ozdemir H., Vural A., Dalkara T., Meltzer H.Y., Saka E. The influence of N-desmethylclozapine and clozapine on recognition memory and BDNF expression in hippocampus. Brain Res. Bull. 2011; 84 (2): 144-150. DOI: 10.1016/j.brainresbull.2010.11.014. PMID: 21134422

65. Barrientos R.M., Sprunger D.B., Campeau S., Higgins E.A., Watkins L.R., Rudy J.W., Maier S.F. Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience. 2003; 121 (4): 847-853. DOI: 10.1016/S0306-4522(03)00564-5. PMID: 14580934

66. Calsavara A.C., Soriani F.M., Vieira L.Q., Costa P.A., Rachid M.A., Teixiera A.L. TNFR1 absence protects against memory deficit induced by sepsis possibly through over-expression of hippocampal BDNF. Metab. Brain Dis. 2015; 30 (3): 669-678. DOI: 10.1007/s11011-014-9610-8. DOI: 10.1007/s11011-014-9610-8. PMID: 25148914

67. Ostrova I.V., Avrushchenko M.Sh. Expression of Brain-Derived Neurotrophic Factor (BDNF) increases the resistance of neurons to death in the postresuscitation period. Obshchaya Reanimatologiya = General Reanimatology. 2015; 11 (3): 45-53. DOI: 10.15360/1813-9779-2015-3-45-53. [In Russ., In Engl.]

68. Chen A., Xiong L.J., Tong Y., Mao M. The neuroprotective roles of BDNF in hypoxic ischemic brain injury (review). Biomed. Rep. 2013; 1 (2): 167-176. DOI: 10.3892/br.2012.48. PMID: 24648914

69. Géral C., Angelova À., Lesieur S. From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF). Pharmaceutics. 2013; 5 (1): 127-167. DOI: 10.3390/pharmaceutics5010127. PMID: 24300402

70. Kondo S., Kohsaka S., Okabe S. Long-term changes of spine dynamics and microglia after transient peripheral immune response triggered by LPS in vivo. Mol. Brain. 2011; 4: 27. DOI: 10.1186/1756-6606-4-27. PMID: 21682853

71. Sharshar T., Polito A., Checinski A., Stevens R.D. Septic-associated encephalopathy-everything starts at a microlevel. Crit. Care. 2010; 14 (5): 199. DOI: 10.1186/cc9254. PMID: 21067627

72. De Backer D. Hemodynamic management of septic shock. Curr. Infect. Dis. Rep. 2006; 8 (5): 366–372. DOI: 10.1007/s11908-006-0047-z. PMID: 16934195

73. Jeremias I.C., Victorino V.J., Machado J.L., Barroso W.A, Ariga S.K., Lima T.M., Soriano F.G. The severity of cecal ligature and puncture-induced sepsis correlates with the degree of encephalopathy, but the sepsis does not lead to acute activation of spleen lymphocytes in mice. Mol. Neurobiol. 2016; 53 (5): 3389-3399. DOI: 10.1007/s12035-015-9290-3. PMID: 26081155

74. Nadeau S., Rivest S. Endotoxemia prevents the cerebral inflammatory wave induced by intraparenchymal lipopolysaccharide injection: role of glucocorticoids and CD14. J. Immunol. 2002; 169 (6): 3370–3381. DOI: 10.4049/jimmunol.169.6.3370. PMID: 12218159

75. Han F., Yu H., Tian C., Li S., Jacobs M.R., Benedict-Alderfer C., Zheng Q.Y. Role for Toll-like receptor 2 in the immune response to Streptococcus pneumoniae infection in mouse otitis media. Infect. Immun. 2009; 77 (7): 3100–3108. DOI: 10.1128/IAI.00204-09. PMID: 19414550

76. Ock J., Jeong J., Choi W.S., Lee W.H., Kim S.H., Kim I.K., Suk K. Regulation of Toll-like receptor 4 expression and its signaling by hypoxia in cultured microglia. J. Neurosci. Res. 2007; 85 (9): 1989–1995. DOI: 10.1002/jnr.21322. PMID: 17461416

77. Riedemann N.C., Guo R.F., Ward P.A. The enigma of sepsis. J. Clin. Invest. 2003; 112 (4): 460–467. DOI: 10.1172/JCI19523. PMID: 12925683

78. Ziaja M., Pyka J., Ciombor J., Plonka P. Kinetics of nitric oxide release in neonatal and mature rat brain during endotoxemia, as studied by diethyldithiocarbamate spin trapping. Curr. Top Biophys. 2005; 29 (1–2): 73–82.

79. Guo R.F., Riedemann N.C., Ward P.A. Role of C5a-C5aR interaction in sepsis. Shock. 2004; 21 (1): 1–7. DOI: DOI: 10.1097/01.shk.000010 5502.75189.5e. PMID: 14676676

80. Kunze K. Metabolic encephalopathies. J. Neurol. 2002; 249 (9): 1150– 1159. DOI: 10.1007/s00415-002-0869-z. PMID: 12242532

81. Kushimoto S., Gando S., Saitoh D., Ogura H., Mayumi T., Koseki K., Ikeda T., Ishikura H., Iba T., Ueyama M., Eguchi Y., Otomo Y., Okamoto K., Endo S., Shimazaki S.; Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group. Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma. Thromb. Haemost. 2008; 100 (6): 1099–1105. DOI: 10.1160/TH08-05-0306. PMID: 19132236

82. Weon Y.C., Marsot-Dupuch K., Ducreux D., Lasjaunias P. Septic thrombosis of the transverse and sigmoid sinuses: imaging findings. Neuroradiology. 2005; 47 (3): 197–203. DOI: 10.1007/s00234-004-1313-0. PMID: 15778836

83. Sprung C.L. The role of amino acid changes in septic encephalopathy. In: Vincent J.L. (ed.). Update 1990. Update in Intensive Care and Emergency Medicine. vol 10. Berlin, Heidelberg: Springer Link; 1990: 60-68. DOI: 10.1007/978-3-642-84125-5_6

84. Nakamura T., Kawagoe Y., Matsuda T., Ebihara I., Koide H. Effects of polymyxin B-immobilized fiber hemoperfusion on amino acid imbalance in septic encephalopathy. Blood Purif. 2003; 21 (4-5): 282-286. DOI: 10.1159/000072546. PMID: 12944727

85. Khodakova A., Beloborodova N.V. Microbial metabolites in the blood of patients with sepsis. Crit. Care. 2007; 11 (Suppl 4): P5. DOI: 10.1186/cc5984.

86. Beloborodova N.V., Khodakova A.S., Bairamov I.T., Olenin A.Y. Microbial origin of phenylcarboxylic acids in the human body. Biochemistry (Mosc.). 2009; 74 (12): 1350-1355. DOI: 10.1134/S0006297909120086. PMID: 19961416. [In Russ., In Engl.]

87. Beloborodova N., Bairamov I., Olenin A., Shubina V., Teplova V., Fedotcheva N. Effect of phenolic acids of microbial origin on production of reactive oxygen species in mitochondria and neutrophils. J. Biomed. Sci. 2012; 19: 89. DOI: 10.1186/1423-0127-19-89. PMID: 23061754

88. Beloborodova N.V., Bairamov I.T., Olenin A.Yu., Fedotcheva N.I. Exometabolites of some anaerobic microorganisms of human microflora. Biomed. Khim. 2011; 57 (1): 95-105. PMID: 21516781. [In Russ., In Engl.]

89. Sarshor Y., Beloborodova N., Moroz V., Osipov A., Bedova A., Chernevskaya E. Getsina M. Value of microbial metabolites in blood serum as criteria for bacterial load in the pathogenesis of hemodynamic disorders in critically ill patients. Crit. Care. 2014; 18 (Suppl 1): P208. DOI: 10.1186/cc13398

90. Beloborodova N., Moroz V., Osipov A., Bedova A., Sarshor Y., Vlasenko A., Olenin A. Tyrosine metabolism disorder and the potential capability of anaerobic microbiota to decrease the value of aromatic metabolites in critically ill patients. Crit. Care. 2014; 18 (Suppl 2): P60. DOI: 10.1186/cc14063

91. Beloborodova N.V., Moroz V.V., Bedova A.Yu., Osipov A.A., Sarshor Yu.N.,Chernevskaya E.A. Participation of aromatic microbial metabolites in the development of severe infection and sepsis. Anesteziologiya i Reanimatologiya. 2016; 61 (3): 202-208. [In Russ.]

92. Mizock B.A., Sabelli H.C., Dubin A., Javaid J.I., Poulos A., Rackow E.C. Septic encephalopathy. Еvidence for altered phenylalanine metabolism and comparison with hepatic encephalopathy. Arch. Intern. Med. 1990; 150 (2): 443-449. PMID: 2302019

93. Hörster F., Schwab M.A., Sauer S.W., Pietz J., Hoffmann G.F., Okun J.G., Kölker S., Kins S. Phenylalanine reduces synaptic density in mixed cortical cultures from mice. Pediatr. Res. 2006; 59 (4 Pt 1): 544–548. DOI: 10.1203/01.pdr.0000203091.45988.8d. PMID: 16549526

94. Robain O., Wisniewski H.M., Loo Y.H., Wen G.Y. Experimental phenylketonuria: Effect of phenylacetate intoxication on number of synapses in the cerebellar cortex of the rat. Acta Neuropathol. 1983; 61 (3-4): 313-315. DOI: 10.1007/BF00692004. PMID: 6685965

95. Williams R.A., Mamotte C.D.S., Burnett J.R. Phenylketonuria: an inborn error of phenylalanine metabolism. Clin. Biochem. Rev. 2008; 29 (1): 31-41. PMID: 18566686

96. Zhou G., Kamenos G., Pendem S., Wilson J.X., Wu F. Ascorbate protects against vascular leakage in cecal ligation and puncture-induced septic peritonitis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012; 302 (4): R409-R416. DOI: 10.1152/ajpregu.00153.2011. PMID: 22116513

97. Gamal M., Moawad J., Rashed L., El-Eraky W., Saleh D., Lehmann C., Sharawy N. Evaluation of the effects of Eserine and JWH-133 on brain dysfunction associated with experimental endotoxemia. J. Neuroimmunol. 2015; 281: 9-16. DOI: 10.1016/j.jneuroim.2015.02.008. PMID: 25867462

98. Toklu H.Z., Uysal M.K., Kabasakal L., Sirvanci S., Ercan F., Kaya M. The effects of riluzole on neurological, brain biochemical, and histological changes in early and late term of sepsis in rats. J. Surg. Res. 2009; 152 (2): 238-248. DOI: 10.1016/j.jss.2008.03.013. PMID: 18718604

99. Moss R.F., Parmar N.K., Tighe D., Davies D.C. Adrenergic agents modify cerebral edema and microvessel ultrastructure in porcine sepsis. Crit. Care Med. 2004; 32 (9): 1916-1921. PMID: 15343022

100. Li R., Tong J., Tan Y., Zhu S., Yang J., Ji M. Low molecular weight heparin prevents lipopolysaccharide induced-hippocampus-dependent cognitive impairments in mice. Int. J. Clin. Exp. Pathol. 2015; 8 (8): 8881-8891. PMID: 26464629

101. Esen F., Senturk E., Ozcan P.E., Ahishali B., Arican N., Orhan N., Ekizoglu O., Kucuk M., Kaya M. Intravenous immunoglobulins prevent the breakdown of the blood-brain barrier in experimentally induced sepsis. Crit. Care Med. 2012; 40 (4): 1214-1220. DOI: 10.1097/CCM. 0b013e31823779ca. PMID: 22202704

102. Busund R., Koukline V., Utrobin U., Nedashkovsky E. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med. 2002; 28 (10): 1434-1439. DOI: 10.1007/s00134-002-1410-7. PMID: 12373468

103. Pandharipande P.P., Sanders R.D., Girard T.D., McGrane S., Thompson J.L., Shintani A.K., Herr D.L., Maze M., Ely E.W. MENDS investigators. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit. Care. 2010; 14 (2): R38. DOI: 10.1186/cc8916. PMID: 20233428